Neurology 2003;60:690-695
© 2003 American Academy of Neurology
Medical Hypothesis
Will caloric restriction and folate protect against AD and PD?
Mark P. Mattson, PhD
From the Laboratory of Neurosciences, National Institute on Aging, Gerontology Research Center, Baltimore, MD.
Address correspondence and reprint requests to Dr. Mark P. Mattson, Laboratory of Neurosciences, National Institute on Aging, Gerontology Research Center 4F01, 5600 Nathan Shock Drive, Baltimore, MD 21224; e-mail: mattsonm{at}grc.nia.nih.gov
Recent epidemiologic studies of different sample populations have suggested that the risk of AD and PD may be increased in individuals with high-calorie diets and in those with increased homocysteine levels. Dietary restriction and supplementation with folic acid can reduce neuronal damage and improve behavioral outcome in mouse models of AD and PD. Animal studies have shown that the beneficial effects of dietary restriction result, in part, from increased production of neurotrophic factors and cytoprotective protein chaperones in neurons. By keeping homocysteine levels low, folic acid can protect cerebral vessels and can prevent the accumulation of DNA damage in neurons caused by oxidative stress and facilitated by homocysteine. Although further studies are required in humans, the emerging data suggest that high-calorie diets and elevated homocysteine levels may render the brain vulnerable to neurodegenerative disorders.
This article has been cited by other articles:

|
 |

|
 |
 
J. Joseph, G. Cole, E. Head, and D. Ingram
Nutrition, Brain Aging, and Neurodegeneration
J. Neurosci.,
October 14, 2009;
29(41):
12795 - 12801.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Gardiner, D. Barton, R. Overall, and J. Marc
Neurotrophic Support and Oxidative Stress: Converging Effects in the Normal and Diseased Nervous System
Neuroscientist,
February 1, 2009;
15(1):
47 - 61.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. H. DeLegge and A. Smoke
Neurodegeneration and Inflammation
Nutr Clin Pract,
February 1, 2008;
23(1):
35 - 41.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Bengmark
Advanced Glycation and Lipoxidation End Products-Amplifiers of Inflammation: The Role of Food
JPEN J Parenter Enteral Nutr,
September 1, 2007;
31(5):
430 - 440.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Qin, T. Yang, L. Ho, Z. Zhao, J. Wang, L. Chen, W. Zhao, M. Thiyagarajan, D. MacGrogan, J. T. Rodgers, et al.
Neuronal SIRT1 Activation as a Novel Mechanism Underlying the Prevention of Alzheimer Disease Amyloid Neuropathology by Calorie Restriction
J. Biol. Chem.,
August 4, 2006;
281(31):
21745 - 21754.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Chen, S. M. Zhang, M. A. Schwarzschild, M. A. Hernan, G. Logroscino, W. C. Willett, and A. Ascherio
Folate Intake and Risk of Parkinson's Disease
Am. J. Epidemiol.,
August 15, 2004;
160(4):
368 - 375.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Muller, K. Renger, and W. Kuhn
Levodopa-Associated Increase of Homocysteine Levels and Sural Axonal Neurodegeneration
Arch Neurol,
May 1, 2004;
61(5):
657 - 660.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Vellas and A. Sinclair
Commentary: Insulin Resistance, Obesity, and the Risk of Neurodegenerative Diseases
J Gerontol A Biol Sci Med Sci,
February 1, 2004;
59(2):
M189 - M189.
[Full Text]
[PDF]
|
 |
|
|